Abstract

BackgroundThere are increasing reports on nosocomial Mycobacterium massiliense infection, but septic arthritis and osteomyelitis because of that microorganism is rare. This report focuses on the clinical aspects of M. massiliense arthritis outbreak concurrent with soft tissue infection.Case presentationAn outbreak of septic arthritis among patients who had been injected at a single clinic occurred in South Korea between April and September 2012. This may be associated with repeated injection of triamcinolone contaminated with M. massiliense. Nine of the Korean patients visited our hospital complaining of painful swelling of the knees. During treatment course, patients are suffered from soft tissue abscess around the injection site. Acid-fast bacilli culture for infected tissue was positive in five patients, and polymerase chain reaction for non-tuberculous mycobacteria was positive in four patients. They were treated with antibiotics, repeated arthroscopic surgeries, incision and drainage for a long time. All patients were eventually cured but three patients have suffered from a decreased range of motion.ConclusionEarly clinical suspicion and microbiological diagnosis are key factors in reducing morbidity since septic arthritis with M. massiliense manifests late after the injection and treatment of it is a laborious process.

Highlights

  • There are increasing reports on nosocomial Mycobacterium massiliense infection, but septic arthritis and osteomyelitis because of that microorganism is rare

  • Non-tuberculous mycobacteria (NTM) are ubiquitous in nature widely found in soil, wastewater, and other materials [1]

  • Mycobacterium abscessus complex is rapidly growing mycobacteria (RGM) characterized by growth in solid agar media within seven days and subclassified into three closely related subspecies of M. abscessus, M. massiliense, and M. bolletii [1]

Read more

Summary

Conclusion

The patients were treated with long term IV and oral antibiotics combined with repeated surgical interventions. M. massiliense is an emerging pathogen of soft tissue infection associated with procedure or surgery, septic arthritis and osteomyelitis rarely occur and its clinical information and therapeutic options are still not fully understood. We report this outbreak of septic arthritis by M. massiliense with characteristics of patients, clinical manifestations, laboratory and synovial fluid analysis, treatment duration and progress, highlight the difficulty in treating the M. massiliense infection and expect it to be a help in the diagnosis and treatment of septic arthritis caused by M. massiliense. Author details 1 Division of Infectious Disease, Department of Internal Medicine, Soon‐ chunhyang University Hospital, 59 Daesagwan‐ro, Yongsan‐gu, Seoul, Korea.

Background
16 S 32 I
Findings
Discussion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.